Integrated Quantitative Investments LLC Invests $435,000 in HCA Healthcare, Inc. (NYSE:HCA)

Integrated Quantitative Investments LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,450 shares of the company’s stock, valued at approximately $435,000.

Several other institutional investors have also recently made changes to their positions in HCA. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $39,000. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare in the fourth quarter worth about $31,000. Tidemark LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $36,000. Activest Wealth Management increased its holdings in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. lifted its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 4.8 %

Shares of HCA opened at $332.53 on Friday. The business has a fifty day moving average of $327.23 and a 200 day moving average of $339.87. The company has a market cap of $81.87 billion, a PE ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company earned $5.90 earnings per share. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HCA shares. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.